Douglas E. Coltharp - 10 Feb 2023 Form 4 Insider Report for Encompass Health Corp (EHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2023, 16:02:20 UTC
Prior SEC filing
04 Jan 2023
Next SEC filing
22 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp

Key filing fact

Douglas E. Coltharp filed Form 4 for Encompass Health Corp (EHC) on 13 Feb 2023.

Key facts

  • This page summarizes Douglas E. Coltharp's Form 4 filing for Encompass Health Corp (EHC).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Feb 2023, 16:02.

Change

  • Previous filing in this sequence was filed on 04 Jan 2023.
  • Current net transaction value: -$728,505.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Options Exercise

Transaction value
$359,153
Shares
+17,895
Change %
+34%
Price
$20.07
Shares after
70,992
Date
10 Feb 2023
Ownership
Direct
EHC transaction

Encompass Health Common Stock

Sale

Transaction value
$1,087,658
Shares
-17,895
Change %
-25%
Price
$60.78
Shares after
53,097
Date
10 Feb 2023
Ownership
Direct
Footnotes
F1
EHC holding

Encompass Health Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
125,631
Date
10 Feb 2023
Ownership
By irrevocable trust for the benefit of children

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EHC transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-17,895
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Feb 2023
Ownership
Direct
Underlying class
Encompass Health Common Stock
Underlying amount
17,895
Exercise price
$20.07
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.78 to $60.84, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

Footnote F2

The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .